enkephalin, and A1 agonist cyclopentyl adenosine) caused delayed increase in phosphoinositide (PI) hydrolysis (8-to 10-fold) that was strongly inhibited by overexpression of dominant-negative PLC-␦1(E341R/D343R; 65-76%) or constitutively active RhoA(G14V). The response coincided with capacitative Ca 2ϩ influx and was not observed in the absence of extracellular Ca 2ϩ , but was partly inhibited by nifedipine (16 -30%) and strongly inhibited by SKF-96365, a blocker of store-operated Ca 2ϩ channels. Treatment of the cells with a Gq/13-coupled receptor agonist, CCK-8, caused only transient, PLC-␤1-mediated PI hydrolysis. Unlike Gi/o-coupled receptor agonists, CCK-8 activated RhoA and stimulated RhoA:PLC-␦1 association. Inhibition of RhoA activity with C3 exoenzyme or by overexpression of dominant-negative RhoA(T19N) or G␣13 minigene unmasked a delayed increase in PI hydrolysis that was strongly inhibited by coexpression of PLC-␦1(E341R/D343R) or by SKF-96365. Agonist-independent capacitative Ca 2ϩ influx induced by thapsigargin stimulated PI hydrolysis (8-fold), which was partly inhibited by nifedipine (ϳ25%) and strongly inhibited by SKF-96365 (ϳ75%) and in cells expressing PLC-␦1(E341R/D343R). Agonist-independent Ca 2ϩ release or Ca 2ϩ influx via voltage-gated Ca 2ϩ channels stimulated only moderate PI hydrolysis (2-to 3-fold), which was abolished by PLC-␦1 antibody or nifedipine. We conclude that PLC-␦1 is activated by Gi/o-coupled receptor agonists that do not activate RhoA. The activation is preferentially mediated by Ca 2ϩ influx via store-operated Ca 2ϩ channels. phospholipase C; G protein FOUR FAMILIES OF phosphoinositide-specific phospholipases (PI-PLC), containing a total of eleven distinct isozymes (PLC-␤1, -␤2, -␤3, -␤4; PLC-␥1, -␥2; PLC-␦1, -␦2, -␦3, -␦4; and PLC-⑀) have been cloned and characterized (13, 19, 41, 42 -dependent, membrane-targeting C2 domain (10 -13, 16, 42) . A long COOHterminal tail is a characteristic feature of PLC-␤ isozymes and mediates G␣-dependent binding and activation of PLC-␤1 (13, 22, 42, 46) . PLC-␤2 and PLC-␤3 are activated via binding of their PH domains to G␤␥ subunits, particularly G␤␥ i (5, 6, 20, 29, 31, 33, 39) . PLC-⑀ contains two COOH-terminal Rasassociating domains and a Ras guanine nucleotide exchange factor motif and is variously activated by Ras, Rap, G␣ 12 , G␤␥, and RhoA (27, 47) . PLC-␥ isozymes are activated by tyrosine phosphorylation of two conserved residues (Tyr   771 and Tyr 783 ) via receptor tyrosine kinases (13, 42) . The PH domain is essential for activation of PLC-␦, and its deletion abolishes PLC-␦ activity (2, 8, 15) . The PH domain of PLC-␦ binds phosphatidylinositol 4,5-bisphosphate (PIP 2 ), which anchors the enzyme to the plasma membrane and enhances its catalytic activity (15) . Although the PH domain of PLC-␦ binds G␤␥, the binding is too weak to induce activation of PLC-␦ (15, 44) . Four specific receptors (␣ 1B -and ␣ 1D -adrenoceptors, ␣-thromboxane receptors, and oxytocin receptors) can activate PLC-␦ via coupling to the atypical G protein (G␣ h ), also known as transglutaminase-II (3, 18, 40) . The mechanism of PLC-␦ activation via G␣ h is not known. A recent study suggests that PLC-␦ is activated by hypotonicity in some neurons; the effect is mediated by neuromodulin, a neuronal, membrane-anchored osmosensory protein, but the mechanism has not been determined (7) .
PLC-␦1, the most abundant and widely expressed isoform of PLC-␦, is typically activated by Ca 2ϩ in the range of 0.1-10 M (1, 26, 28). Despite its sensitivity to Ca 2ϩ (ϳ100-fold higher than that of PLC-␤ or PLC-␥), PLC-␦ is not activated by agonists that mobilize intracellular Ca 2ϩ , possibly because PLC-␦ is inactivated by PLC-␤-dependent generation of protein kinase C (PKC) and inositol trisphosphate (IP 3 ); the latter competes with PIP 2 for binding to PLC-␦ (1, 4). Ca 2ϩ influx induced by Ca 2ϩ ionophores or via voltage-gated Ca 2ϩ channels (e.g., depolarizing concentrations of KCl) causes moderate PI hydrolysis, but the specific isozyme mediating this effect has not been identified (21, 43) . In a recent study, activation of PLC-␦ by capacitative Ca 2ϩ influx induced by thapsigargin or bradykinin was observed only after overexpression of PLC-␦ (23) .
In this study, we have identified a unique mechanism for activation of PLC-␦1 via G i/o -coupled receptors. The inability of G q/13 -coupled receptors to activate PLC-␦1 reflected concurrent activation of RhoA.
EXPERIMENTAL PROCEDURES
Preparation of dispersed and cultured muscle cells. Smooth muscle cells were isolated from the circular muscle layer of rabbit stomach by sequential enzymatic digestion, filtration, and centrifugation, as described previously (32, 36 -38) . In some experiments, cells were also isolated from the circular or longitudinal muscle layers of small intestine. The cells were resuspended in enzyme-free medium con-sisting of 120 mM NaCl, 4 mM KCl, 2.6 mM KH2PO4, 2 mM CaCl2, 0.6 mM MgCl 2, 25 mM HEPES, 14 mM glucose, and 2.1% Eagle's essential amino acid mixture. The cells were harvested by filtration through 500-m Nitex mesh and centrifuged two times at 350 g for 10 min. In experiments with blocking antibodies, the cells were permeabilized with saponin (35 g/ml) in a medium containing 100 nM Ca 2ϩ and resuspended in 1.5 mM ATP and an ATP-regenerating system (5 mM creatine phosphate and 10 U/ml creatine phosphokinase). In some experiments, the muscle cells were cultured in DMEM containing 10% FBS until they attained confluence and were used in the first passage.
Assay of PLC activity. Inositol phosphate formation was measured as described previously using anion exchange chromatography (29, (31) (32) (33) G␣13 minigene (MGLHDNLKQLMLQ), dominant-negative PLC-␦1(E341R/D343R) and RhoA(T19N), and constitutively active RhoA(G14V) were subcloned into the multiple cloning site (EcoRI) of the eukaryotic expression vector (PLC-␦1: pcDNA3; RhoA: pEXV), and a myc-tag incorporated in the NH2 terminus. Recombinant plasmid cDNA (2 g) was transiently transfected in cultured smooth muscle cells treated with Lipofectamine Plus reagent for 48 h. The cells were cotransfected with 1 g pGreen Lantern-1 to monitor expression. Control cells were cotransfected with 2 g vector (pEXV or pcDNA3) and 1 g pGreen Lantern-1 DNA. Transfection efficiency (ϳ80%) was monitored by the expression of green fluorescent protein using FITC filters (36, 38) .
Association of PLC-␦1 and activated RhoA. Muscle cells were lysed by incubation for 30 min at 4°C in 10 mM Tris (pH 7.5), 50 mM NaCl, 1% Triton X-100, and 60 mM octylglucoside, and the lysate was centrifuged at 15,000 g for 30 min. The supernatant was precleared by incubation with 0.1% albumin-coated protein A-Sepharose for 6 h at 4°C and then incubated overnight with polyclonal PLC-␦1 antibody at a final concentration of 2 g/ml. Protein A-Sepharose was then added for 2 h, and the mixture was centrifuged for 5 min. The PLC-␦1 immunoprecipitates were washed four times with lysis buffer and boiled in Laemmli buffer. Samples were separated by SDS-PAGE in 12% acrylamide gel, electrotransferred to nitrocellulose paper, and probed with antibody to RhoA or PLC-␦1. After incubation with secondary antibody conjugated with horseradish peroxidase, the proteins were visualized using enhanced chemiluminescence. The intensity of the protein band on Hyperfilm-ECL was determined by densitometry.
Assay for activated RhoA. Activated RhoA was measured in freshly dispersed muscle cells by a technique using Rhotekin, as described previously (37) . Muscle cell lysates (100 g protein) were incubated with glutathione-agarose slurry of Rhotekin at 4°C for 45 min. The beads were washed three times with the washing buffer containing 50 mM Tris ⅐ HCl (pH 7.2), 1% Triton X-100, 150 mM NaCl, 10 mM MgCl2, 0.1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, and 10 g/ml leupeptin. GTP-bound RhoA was solubilized in Laemmli sample buffer and analyzed by 15% SDS-PAGE followed by Western blot and chemiluminescence.
Materials. Myo-[ 3 H]inositol was obtained from New England Nuclear (Boston, MA); polyclonal antibodies to RhoA, PLC-␦1, and various isoforms of PLC-␤ were from Santa Cruz Biotechnology (Santa Cruz, CA); pGreen Lantern-1 and Lipofectamine Plus reagent were from Life Technologies GIBCO-BRL (Rockville, MD); SKF-96365 was from Biomol (Plymouth Meeting, PA); and all other reagents were from Sigma. RhoA cDNA was a gift of Dr. Andrea Todisco (University of Michigan).
RESULTS

Activation of PLC-␦1 by Ca
2ϩ
. Ca 2ϩ concentrations in the range 0.1-1.0 M stimulated PI hydrolysis (PLC activity) in permeabilized gastric smooth muscle cells in a concentrationdependent fashion [maximal 8-to 10-fold increase in PLC activity with 1 M Ca 2ϩ (5,021 Ϯ 468 cpm/mg protein above basal); Fig. 1A ]. The isoform of PLC activated by Ca 2ϩ in smooth muscle was identified by functional blockade with specific antibodies. Our previous studies had shown that all PI-specific PLC isozymes, including PLC-␤1, -2, -3, and -4, PLC-␥1, and PLC-␦1, were expressed in gastrointestinal smooth muscle (29, 32) . Preincubation of permeabilized muscle cells for 1 h with PLC-␦1 antibody (10 g/ml) inhibited maximal Ca 2ϩ -stimulated PLC activity by 84 Ϯ 2%, whereas preincubation with PLC-␤1, PLC-␤2, PLC-␤3, PLC-␤4, or PLC-␥1 antibody had no effect (Fig. 1B) . The pattern of inhibition by PLC antibodies implied that Ca 2ϩ specifically activated PLC-␦1.
Dual activation of PLC-␤3 and PLC-␦1 by G i -coupled receptors.
Previous studies in these smooth muscle cells had shown that G i/o -coupled receptor agonists elicit an initial, transient (ϳ2 min) increase in PI hydrolysis mediated by G␤␥ i/o -dependent activation of PLC-␤3 (29, 31, 33, 36) . As shown in Fig. 2 ]enkephalin or DPDPE) caused an initial PLC-␤3-dependent increase in PI hydrolysis followed by a delayed increase (ϳ8-fold above basal levels). The delayed increase in PI hydrolysis was virtually abolished in cells expressing dominant-negative PLC-␦1(E341R/D343R), whereas the initial increase was not affected. The delayed increase in PI hydrolysis was also inhibited by expression of a constitutive active RhoA. The significance of this observation is discussed subsequently.
A similar 8-to 10-fold increase in PI hydrolysis was elicited by G i-1 -and G i-3 -coupled receptor agonists [somatostatin and the A 1 agonist cyclopentyl adenosine (CPA), respectively; Fig.  3A ]. The increase induced by these agonists was strongly inhibited in cells expressing PLC-␦1(E341R/D343R) (Fig. 3A) . The delayed increase in PI hydrolysis was not observed in the absence of extracellular Ca 2ϩ and was virtually abolished by SKF-96365, an inhibitor of store-operated and voltage-gated Ca 2ϩ influx (Fig. 3A ).
An identical pattern was obtained in freshly dispersed muscle cells with all three G i -coupled receptor agonists (Fig. 3B) . ]enkephalin (DPDPE, 1 M) for 10 min. The reaction was terminated at different time points, and PI hydrolysis was measured using anion exchange chromatography, as described in EXPERIMENTAL PROCEDURES. PI hydrolysis was expressed as cpm per mg protein of total inositol phosphates. DPDPE caused a biphasic increase in PI hydrolysis only in control cells expressing vector alone. The delayed increase in PI hydrolysis was strongly inhibited in cells expressing PLC-␦1(E341R/D343R) and RhoA(G14V channels and, to a lesser extent, via voltage-gated Ca 2ϩ channels (Fig. 3B) .
Selective activation of PLC-␤ by G q -coupled receptors. Treatment of dispersed muscle cells with CCK-8 elicited a transient stimulation of PI hydrolysis (Fig. 4A) . The initial increase was not followed by a delayed increase in PI hydrolysis, was inhibited by 83 Ϯ 5% in muscle cells preincubated for 60 min with PLC-␤1 antibody (10 g/ml), but was not affected in cells preincubated with PLC-␥1 or PLC-␦1 antibody (Fig. 4B) . Earlier studies had shown that CCK-stimulated PI hydrolysis in permeabilized muscle cells was blocked by incubation with G␣ q antibody (32) . The effectiveness of G protein and PLC-␤ antibodies in blocking agonist-induced, G protein-dependent PI hydrolysis in permeabilized smooth muscle was characterized in previous studies (29, (31) (32) (33) (34) 36) .
Suppression of PLC-␦1 stimulation by activated RhoA. We postulated that the difference in the ability of G i/o -and G qcoupled receptor agonists to elicit activation of PLC-␦1 could reflect the difference in their ability to stimulate RhoA activity. Previous studies in smooth muscle cells had shown that G qcoupled receptors (e.g., CCK A , m 3 ) that activate PLC-␤1 also activate G␣ 13 and RhoA (37, 38) . In contrast, G i -coupled receptors (somatostatin receptor 3, ␦-opioid, A 1 , m 2 ) that activate PLC-␤3 also activate Cdc42/Rac1 and PI 3-kinase but not G␣ 13 or RhoA (36, 48) .
CCK-8 induced RhoA:PLC-␦1 association (Fig. 5A ) and stimulated RhoA activity in a time-dependent fashion (Fig.  5B) . In contrast, somatostatin, DPDPE, and CPA did not stimulate RhoA activity (Fig. 5C) . Treatment of freshly dispersed muscle cells with the RhoA inhibitor, C3 exoenzyme, inhibited CCK-induced RhoA:PLC-␦1 association (Fig. 5A ) and RhoA activity (Fig. 5C ) and unmasked a delayed increase in PI hydrolysis (Fig. 6) . The initial increase measured in the first minute and mediated by PLC-␤1 as shown in Fig. 4B was not affected by C3 exoenzyme. The delayed increase (measured 5 min after addition of CCK-8) coincided with the period of capacitative Ca 2ϩ influx and was not observed in the absence of extracellular Ca 2ϩ . Neither the initial nor the delayed increase in PI hydrolysis was affected by the PKC inhibitor bisindolylmaleimide (1 M) or the Rho kinase inhibitor Y-27632 (1 M; data not shown).
A delayed increase in PI hydrolysis induced by CCK-8 was also unmasked in cultured smooth muscle cells expressing dominant-negative RhoA (T19N; Fig. 7A ) or G␣ 13 minigene (Fig. 7B) . The delayed PI hydrolysis caused by CCK-8 reflected activation of PLC-␦1, since it could not be elicited in cultured smooth muscle cells coexpressing RhoA(T19N) and PLC-␦1(E341R/D343R) or coexpressing G␣ 13 minigene and PLC-␦1(E341R/D343R) (Fig. 7, A and B) . Expression of G␣ 13 minigene inhibited RhoA:PLC-␦1 association (Fig. 8A ) and RhoA activity (Fig. 8B) . The early phase of PI hydrolysis mediated by PLC-␤1 was not affected by expression of RhoA(T19N), G␣ 13 minigene, or PLC-␦1(E341R/D343R) (data not shown).
Further evidence that association of PLC-␦1 with activated RhoA prevents activation of PLC-␦1 is provided in Fig. 2 , where the delayed increase in PI hydrolysis induced by the G i -coupled receptor agonist DPDPE was virtually abolished in cells expressing a constitutively active RhoA(G14V).
Activation of PLC-␦1 by agonist-independent capacitative Ca 2ϩ influx. The relative importance of Ca 2ϩ influx via storeoperated and voltage-gated Ca 2ϩ channels in stimulating PLC-␦1 activity was examined further using thapsigargin and KCl to activate preferentially store-operated and voltage-gated Ca 2ϩ channels, respectively. Treatment of muscle cells for 20 min with thapsigargin in the absence of Ca 2ϩ followed by addition of 2 mM Ca 2ϩ caused an eightfold increase in PI hydrolysis, similar in magnitude to that elicited by G i -coupled receptor agonists (Fig. 9A) . No increase in PI hydrolysis was observed in the absence of extracellular Ca 2ϩ (data not shown). PI hydrolysis induced by thapsigargin was inhibited strongly (82 Ϯ 6%) by SKF-96365 (Fig. 9A ) and minimally by nifedipine (13 Ϯ 2%). PI hydrolysis induced by thapsigargin in cultured muscle cells (4,039 Ϯ 479 cpm/mg protein) was strongly inhibited (75 Ϯ 5%) in cells overexpressing a PLC-␦1(E341R/D343R) mutant (Fig. 9B) , implying that it was mediated by PLC-␦1. In contrast, Ca 2ϩ influx induced by treatment of intact muscle cells with a depolarizing concentration of KCl (20 mM) or with ␣,␤-methylene ATP, a P 2X receptor agonist, caused only a moderate two-to threefold increase in PI hydrolysis that was abolished by nifedipine (Fig. 10A) . Previous studies in these cells had shown that activation of the P 2X receptor, a ligand-gated cationic channel, depolarizes smooth muscle cells and stimulates Ca 2ϩ influx via voltage-gated Ca 2ϩ channels (34) .
Activation of PLC-␦1 by agonist-independent Ca 2ϩ release. As noted above, PI hydrolysis induced by CCK-8 in permeabilized muscle cells was not affected by preincubation with PLC-␦1 antibody (Fig. 4) , suggesting either that Ca 2ϩ release did not activate PLC-␦1 or that activation of PLC-␦1 was offset by concomitant inhibition by IP 3 and PKC. In the absence of agonist, treatment of permeabilized intestinal circular muscle cells with IP 3 (1 M) caused a significant twofold increase in PI hydrolysis that was abolished in cells preincubated for 60 min with PLC-␦1 antibody (Fig. 10B) . It is possible that the response to Ca 2ϩ release induced by IP 3 might have been attenuated by the inhibitory effect of IP 3 on PLC-␦1 activity. To obviate the confounding effect of IP 3 , the experiments were repeated in intestinal longitudinal muscle cells, which express predominantly IP 3 -insensitive, ryanodine receptors/Ca 2ϩ channels that are highly sensitive to Ca 2ϩ and cADP ribose (24, 25) . Treatment of permeabilized intestinal longitudinal muscle cells with cADP ribose caused a somewhat higher threefold increase in PI hydrolysis, which was inhibited by 73 Ϯ 5% in cells preincubated with PLC-␦1 antibody.
The pattern that emerges from comparison of PLC-␦1 activity induced by G i/o -dependent or -independent capacitative Ca 2ϩ influx with PLC-␦1 activity induced by G proteinindependent Ca 2ϩ influx (KCl; ␣,␤-methylene ATP) or Ca 2ϩ release (IP 3 and cADP ribose) is that the mechanism of Ca 2ϩ entry rather than the magnitude of Ca 2ϩ entry or Ca 2ϩ release is the main determinant of PLC-␦1 activity.
DISCUSSION
This study provides the first evidence that G i/o -coupled receptors can activate PLC-␦1 and that activation is preferentially mediated by capacitative Ca 2ϩ influx. The study also shows that the inability of G q/13 -coupled receptors to activate PLC-␦1 reflects concurrent activation of RhoA, which inactivates PLC-␦1 by binding directly to RhoA or indirectly via RhoGAP (17) . A link between PI-PLC activity and capacitative Ca 2ϩ influx was suggested by earlier studies showing an Muscle cell lysates were incubated with glutathione-agarose slurry of Rhotekin, and GTP-bound RhoA (RhoA activity) was analyzed by SDS-PAGE followed by Western blot analysis. C: freshly dispersed muscle cells were treated with various agonists [CCK-8, somatostatin, ␦-opioid agonist DPDPE (␦), and CPA] for 5 min, and RhoA activity was determined. In some experiments, the cells were preincubated for 3 h with the RhoA inhibitor C3 exoenzyme (C3E). CCK, but not somatostatin, DPDPE, or CPA, stimulated RhoA activity and induced association of PLC-␦1:RhoA. CCK-induced RhoA activity and association of PLC-␦1:RhoA were blocked by C3 exoenzyme. In all experiments, maximally effective concentrations were used (1 nM for CCK-8 and 1 M for other agonists). Values are means Ϯ SE of 4 -6 experiments. . Capacitative Ca 2ϩ influx was elicited by the addition of 2 mM Ca 2ϩ at 5 min. PI hydrolysis was measured using anion exchange chromatography and expressed as total inositol phosphates (cpm/mg protein). In some experiments, freshly dispersed muscle cells were preincubated for 3 h with the RhoA inhibitor C3 exoenzyme. Inhibition of RhoA had no effect on CCK-induced initial increase in PI hydrolysis but unmasked a delayed increase in PI hydrolysis. Values are means Ϯ SE of 4 experiments.
increase in PI-PLC activity in cells overexpressing PLC-␦1, but the specific requirements of coupling to G i/o and absence of RhoA activity were not addressed (23) .
Previous studies in smooth muscle cells had shown that G i/o -coupled receptor agonists, including all three agonists used in this study, cause an initial G␤␥ i -dependent stimulation of PLC-␤3 activity, resulting in IP 3 -dependent Ca 2ϩ release and contraction (25, 29, 31, 33) . Here we show that these agonists also induce a delayed PI hydrolysis that is virtually abolished in smooth muscle cells expressing a dominantnegative PLC-␦1(E341R/D343R) or a constitutively active RhoA(G14V), implying that PI hydrolysis was mediated by PLC-␦1 and blocked by activated RhoA. Conversely, G q /G␣ 13 . B: parallel studies were done in cultured muscle cells expressing dominant-negative G␣13 minigene or coexpressing G␣13 minigene and PLC-␦1(E341R/D343R). PI hydrolysis was measured at 5 min using anion exchange chromatography and was expressed as total inositol phosphates (cpm/mg protein). Expression of RhoA (T19N) or G␣13 minigene unmasked a delayed increase PI hydrolysis in response to CCK, and this 1). Even Ca 2ϩ release induced by exogenous IP 3 or cADP ribose caused a moderate increase in PLC-␦1 activity. The identity of the PLC isozyme activated by Ca 2ϩ release was confirmed by blockade with PLC-␦1 antibody. A potential increase in PLC-␦1 activity that might result from agonistinduced Ca 2ϩ release would be offset by concurrent inhibition of PLC-␦1 by IP 3 and PKC.
Although this study identifies a physiological mechanism for activation of PLC-␦1 by G i -coupled receptor agonists, the functional role of PLC-␦1 and delayed PI hydrolysis has yet to be elucidated. Conceivably, delayed generation of IP 3 could alter the dynamics of Ca 2ϩ release and Ca 2ϩ uptake in the cell and sarcoplasmic stores, which could result in a more sustained cellular response. Because G i -coupled receptor agonists do not activate RhoA or its downstream effectors PLD and PKC, PLC-␦1 activity becomes the main source of sustained PKC activity in response to these agonists. The effect of sustained PKC activity from this source has not been determined. This notion, however, sheds light on our earlier observation that the initial contractile response of permeabilized smooth muscle cells to Ca 2ϩ was mediated by Ca 2ϩ /calmodulin-dependent myosin light chain (MLC) kinase, whereas the sustained response was dependent on PKC (30) . Activation of PKC was probably a consequence of PI hydrolysis mediated by Ca 2ϩ -stimulated PLC-␦1, resulting in PKC-mediated inhibition of MLC phosphatase (36) . Consistent with this notion, the sustained contraction induced by exogenous Ca 2ϩ was suppressed in cells treated with PLC-␦1 antibody. Accordingly, studies of "Ca 2ϩ sensitization," in which permeabilized smooth muscle is exposed sequentially to Ca 2ϩ -free and Ca 2ϩ -containing media, should take into account the probability that Ca 2ϩ -mediated activation of PLC-␦1 would generate signaling molecules that could influence the response.
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